INSPRITEC

Welcome to the Brand page for “INSPRITEC”, which is offered here for Diagnostic test kits comprised of medical diagnostic reagents used for screening and detecting diseases; diagnostic test kits comprised of medical diagnostic reagents used for screening and detecting cancer;medical diagnostic services, medical testing for diagnostic or treatment purposes; medical diagnostic services, medical diagnostic testing, monitoring and reporting services;providing medical and scientific research in the field of cancer; scientific research for medical purposes and analyses in the field of cancer; product research and development services; research, development, engineering, testing, and analytical services in the fields of vaccines, screening and detecting diseases, and medicine; research and development of vaccines, immunotherapies, and medical diagnostics kits; research and development of diagnostic test kits for screening and detecting diseases; laboratory research and testing services relating to vaccines, screening and detecting diseases, and medicine; consulting services in the fields of science and medicine, consulting services relating to vaccine development and the development of methods for screening and detecting diseases; scientific and technological services and research and design relating thereto, the development of vaccines, methods for screening and detecting diseases, and medicine; industrial analysis and research services, industrial research in the field of development of vaccines, screening and detecting diseases, and medicine; computer services, design and development of computer hardware and software; computer services, software as a service (saas) services featuring software that provides information, test results for screening and detecting diseases, and the analysis, evaluation, and reporting of those test results to healthcare professionals and patients;.

Its status is currently believed to be active. Its class is unavailable. “INSPRITEC” is believed to be currently owned by “Vigilant Biosciences, Inc.”